PUBLICATION
            Mef2c factors are required for early but not late addition of cardiomyocytes to the ventricle
- Authors
 - Kula-Alwar, D., Marber, M.S., Hughes, S.M., Hinits, Y.
 - ID
 - ZDB-PUB-201128-8
 - Date
 - 2020
 - Source
 - Developmental Biology 470: 95-107 (Journal)
 - Registered Authors
 - Hinits, Yaniv, Hughes, Simon M.
 - Keywords
 - Cardiomyocyte, Growth, Second heart field, Zebrafish, mef2c
 - MeSH Terms
 - 
    
        
        
            
                
- Cell Proliferation
 - Myocytes, Cardiac/physiology*
 - MEF2 Transcription Factors/genetics
 - MEF2 Transcription Factors/metabolism*
 - Organogenesis
 - Homeobox Protein Nkx-2.5/genetics
 - Homeobox Protein Nkx-2.5/metabolism
 - Mutation
 - Organ Size
 - Animals
 - Latent TGF-beta Binding Proteins/genetics
 - Latent TGF-beta Binding Proteins/metabolism
 - Heart/embryology*
 - Zebrafish Proteins/genetics
 - Zebrafish Proteins/metabolism*
 - Cell Differentiation
 - Heart Ventricles/embryology*
 - Zebrafish
 - Muscle Proteins/genetics
 - Muscle Proteins/metabolism*
 - Gene Expression Regulation, Developmental
 
 - PubMed
 - 33245870 Full text @ Dev. Biol.
 
            Citation
        
        
            Kula-Alwar, D., Marber, M.S., Hughes, S.M., Hinits, Y. (2020) Mef2c factors are required for early but not late addition of cardiomyocytes to the ventricle. Developmental Biology. 470:95-107.
        
    
                
                    
                        Abstract
                    
                    
                
                
            
        
        
    
        
            
            
 
    
    
        
    
    
    
        
                During heart formation, the heart grows and undergoes dramatic morphogenesis to achieve efficient embryonic function. Both in fish and amniotes, much of the growth occurring after initial heart tube formation arises from second heart field (SHF)-derived progenitor cell addition to the arterial pole, allowing chamber formation. In zebrafish, this process has been extensively studied during embryonic life, but it is unclear how larval cardiac growth occurs beyond 3 days post-fertilisation (dpf). By quantifying zebrafish myocardial growth using live imaging of GFP-labelled myocardium we show that the heart grows extensively between 3 and 5 dpf. Using methods to assess cell division, cellular development timing assay and Kaede photoconversion, we demonstrate that proliferation, CM addition, and hypertrophy contribute to ventricle growth. Mechanistically, we show that reduction in Mef2c activity (mef2ca+/-;mef2cb-/-), downstream or in parallel with Nkx2.5 and upstream of Ltbp3, prevents some CM addition and differentiation, resulting in a significantly smaller ventricle by 3 dpf. After 3 dpf, however, CM addition in mef2ca+/-;mef2cb-/- mutants recovers to a normal pace, and the heart size gap between mutants and their siblings diminishes into adulthood. Thus, as in mice, there is an early time window when SHF contribution to the myocardium is particularly sensitive to loss of Mef2c activity.
            
    
        
        
    
    
    
                
                    
                        Genes / Markers
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Expression
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Phenotype
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Mutations / Transgenics
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Human Disease / Model
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Sequence Targeting Reagents
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Fish
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Orthology
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Engineered Foreign Genes
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Mapping